RadNet, Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- RadNet, Inc. (NYSE: RDNT) operates as a leading national provider of freestanding outpatient diagnostic imaging services in the United States. The company offers a comprehensive range of medical imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related services; it also provides image exchange networks, teleradiology services, and artificial intelligence (AI)-assisted diagnostic tools under brands such as DeepHealth for AI applications. RadNet serves patients, referring physicians, health systems, and health plans through a network of over 380 imaging centers across major markets including California, New York, New Jersey, Maryland, Delaware, Florida, and Connecticut. Founded in 1980 and headquartered in Los Angeles, California, the company focuses on high-quality, cost-effective outpatient imaging in the healthcare services industry, targeting urban and suburban demographics with a mix of fixed-site centers and joint ventures with hospitals. In recent developments, RadNet expanded its footprint through the acquisition of several imaging centers and strategic joint ventures, including a significant partnership with Hackensack Meridian Health in New Jersey during 2024; it also launched new AI-enhanced breast imaging solutions and completed a major funding round via convertible notes to support growth initiatives. The company reported robust revenue growth in 2025, driven by volume increases and reimbursement improvements, alongside the opening of new facilities in high-density markets. RadNet maintains no major subsidiaries but operates through various joint ventures and has pursued aggressive de novo expansion in the Southeast and Midwest regions.
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing
Do Options Traders Know Something About RadNet Stock We Don't?
RadNet to Host Men's Health Webinar on June 13, 2026
RadNet to Host Men's Health Webinar on June 13, 2026
Amazon, McDonald Surge Into Jefferies Top Picks Broadcom as Gets Cut
Jefferies updates its list of highest-conviction Buy-rated stocks
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet Q1 Earnings Call Highlights
RadNet (RDNT) Reports Strong Revenue Growth Despite EPS Miss in Q1
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
Will RadNet (RDNT) Report Negative Earnings Next Week? What You Should Know
RadNet and Trinity Health's Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions
RadNet Inc (RDNT) Shares Fall 3.5% -- What GF Score of 84 Tells Investors
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
RadNet Inc (RDNT) Stock Down 4.3% -- Now Undervalued? GF Score: 85/100
24,848 Shares in RadNet, Inc. $RDNT Purchased by Campbell Newman Asset Management Inc.
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions
RadNet Insider Sells 15,000 Shares as Stock Falls 12% in 2026
RadNet CFO Touts “Unprecedented” Volume Momentum, Sees Digital Health as 2026 Growth Engine